Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Mirae Asset
AddedFeb 13, 2024
UpdatedJul 16, 2026
Mirae Asset

Mirae Asset

Operating

Mirae Asset, a South Korean financial group, offers asset management, wealth management, investment banking, and life insurance globally.

Location
Seoul, Seoul, KR
Founded
1997
Firm
Compare
Portfolio
Fundraising
Employees
News
Website

Investments

Genspark
Genspark
Series B extension

Total Raised

$100M

Rounds

1

Series B extension$100MJune 2026
Runway
Runway
Series E

Total Raised

$551.5M

Rounds

7

Series E$315MFebruary 2026
d-Matrix
d-Matrix
Series B

Total Raised

$154M

Rounds

3

Series B$110MSeptember 2023
Ascend Elements
Ascend Elements
Series D

Total Raised

$1.5B

Rounds

13

Series D$460MSeptember 2023
Septerna
Septerna
Series B

Total Raised

$250M

Rounds

2

Series B$150MJuly 2023
AvoMD
AvoMD
Seed

Total Raised

$8M

Rounds

2

Seed$5MJune 2023
Pre-Seed$3MJuly 2021
Ensoma
Ensoma
Series B

Total Raised

$205M

Rounds

3

Series B$85MJanuary 2023
Casma Therapeutics
Casma Therapeutics
Series C

Total Raised

$154.9M

Rounds

4

Series C$46MNovember 2022
Vyriad
Vyriad
Series B

Total Raised

$63.4M

Rounds

4

Series B$29.5MMay 2022
Faze
Faze
Series A

Total Raised

$117.4M

Rounds

2

Series A$100MMarch 2022
Immutable
Immutable

Total Raised

$277.4M

Rounds

4

Series C$200MMarch 2022
OpenSpace
OpenSpace
Series D

Total Raised

$200.4M

Rounds

9

Series D$102MMarch 2022
Pavilion Data Systems
Pavilion Data Systems
Series D

Total Raised

$103M

Rounds

9

Series D$45MJanuary 2022
Animoca Brands
Animoca Brands

Total Raised

$860.9M

Rounds

29

Late Stage Private$358.9MJanuary 2022
Figment
Figment
Late Stage Private

Total Raised

$164.5M

Rounds

7

Series C$110MDecember 2021
Spatial
Spatial
Series B

Total Raised

$47.3M

Rounds

5

Series B$25MDecember 2021
Impossible Foods
Impossible Foods
Public

Total Raised

$1.9B

Rounds

12

Series H$500MNovember 2021
Statespace
Statespace
Series C

Total Raised

$102.1M

Rounds

6

Series C$50MSeptember 2021
Immunitas Therapeutics
Immunitas Therapeutics
Series B

Total Raised

$97M

Rounds

2

Series B$58MAugust 2021
Apeel
Apeel
Late Stage Private

Total Raised

$719.1M

Rounds

12

Series E$250MAugust 2021
Motion2Ai
Motion2Ai
Series A

Total Raised

$14.7M

Rounds

3

Series A$12.6MAugust 2021
FalconX
FalconX

Total Raised

$477M

Rounds

8

Series C$210MAugust 2021
Sonoma Biotherapeutics
Sonoma Biotherapeutics
Series C

Total Raised

$365M

Rounds

4

Series B$265MAugust 2021
XtalPi
XtalPi
Public

Total Raised

$793.5M

Rounds

10

Series C$318.8MSeptember 2020